Integer Holdings Corp (NYSE: ITGR) is a medical device manufacturing company that produces components and systems for implantable and non-implantable medical devices. It generates revenue by manufacturing and selling these components on a transactional basis to medical device original equipment manufacturers. The company operates under the Greatbatch Medical and Lake Region Medical tradenames, as referenced in its FY2025 10-K filed February 23, 2026. As of December 31, 2025, Integer carried $1.207 billion in total principal debt outstanding, with $207.3 million due within three years and $1.0 billion due in the three-to-five-year window, indicating a debt-heavy capital structure. The filing does not disclose segment revenue breakdowns, customer concentration figures, or geographic revenue mix in the excerpts provided.

Revenue model

Transactional manufacturing and sale of medical device components to OEM customers. Revenue is recognized upon delivery of manufactured products.

Products and services

Medical device components and systems sold under the Greatbatch Medical and Lake Region Medical tradenames, covering implantable and non-implantable device applications.

Customers and end markets

Medical device original equipment manufacturers (OEMs). End markets include implantable and non-implantable medical devices. Specific customer names and concentration figures are not supported by the filing excerpts provided.

Value-chain role

Contract manufacturer and component supplier sitting between raw material suppliers and medical device OEM customers.

Geographic exposure

Not supported by the filing excerpts provided.

Source: SEC 10-K, filed 2026-02-23

Industry: Electromedical & Electrotherapeutic Apparatus Peers: Abbott Laboratories AtriCure Inc Enovis Corp Conmed Corp Glaukos Corp NEVRO CORP NUVASIVE INC Paragon 28, Inc. Procept Biorobotics Corp Tandem Diabetes Care Inc